Performance Evaluation of VIDAS® Diagnostic Assays Detecting Anti-Chikungunya Virus IgM and IgG Antibodies: An International Study
Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki, and approved by institutional ethics committee (CEP) of the Faculty of Medicine of the University of São Paulo, Brazil (approval number 4.692.542, dated 5 May 2021), and by the independent e...
| Autores: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2023 |
| País: | Brasil |
| Recursos: | Fundação Oswaldo Cruz (FIOCRUZ) |
| Repositorio: | Repositório Institucional da FIOCRUZ (ARCA) |
| Idioma: | inglés |
| OAI Identifier: | oai:arca.fiocruz.br:icict/60706 |
| Acesso em linha: | https://arca.fiocruz.br/handle/icict/60706 |
| Access Level: | acceso abierto |
| Palavra-chave: | CHIKV ELFA ELISA IgG IgM VIDAS® Capture immunoassay Chikungunya virus Enzyme-linked fluorescent assay Enzyme-linked immunosorbent assay |
| Resumo: | Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki, and approved by institutional ethics committee (CEP) of the Faculty of Medicine of the University of São Paulo, Brazil (approval number 4.692.542, dated 5 May 2021), and by the independent ethics committee Namaste Integrated Services, Lanka, Varanasi, India (approval number BS-IND-001, dated 7 August 2021). |
|---|